ClaroNav Kolahi , a company based in Toronto, Canada, won European regulatory approval for its Navient Cranial navigation system, a product designed to make neurosurgical navigation easy, intuitive, and space-efficient in the OR. Navient Cranial can be used in open or percutaneous procedures to help locate surgical targets within the brain and wher (Read more...)
Uncategorized
Aerie completes enrollment in phase 2 trial of AR-1105
Enrollment is complete in a phase 2 clinical trial of AR-1105 for the treatment of macular edema associated with retinal vein occlusion, Aerie Pharmaceuticals announced in a press release.The trial, which is taking place at 19 U.S. centers, is evaluati…
Uncategorized
Medical Technology Innovation Forum to focus on personalized health care, medicine
OCTANe’s 14th annual Medical Technology Innovation Forum, a meeting centered on bringing together investors, executives and entrepreneurs in the medical technology industry, will focus on personalized health care and medicine this year.The forum will b…
The Science Behind NaturalVue’s Neurofocus Optics® Technology Presented at American Academy of Optometry
ATLANTA–(BUSINESS WIRE)–US-based medical device company and manufacturer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘the Company’) will be presenting the science behin…
3D Printed Cells and Bioinks for Making Implantable Blood Vessels
Researchers based in South Korea and Hong Kong have developed a method to create biomimetic blood vessels by directly 3D printing vascular cells and bioinks containing collagen and vascular tissue extracellular matrix components. The resulting constructs closely mimic natural blood vessels, suggesting that such techniques could pave the way for cus (Read more...)
Study pinpoints cell types linked to age-related macular degeneration
Age-related macular degeneration is one of the leading causes of blindness in the elderly, affecting more than 2 million people in the United States and leading to progressive loss of central vision.